Local treatment to supplement skin ulcers.

Skin channel.

Apply on a compress a thickness of 1 centimeter of paste.

Gently lay on the ulceration: Hold with a conventional bandage

Class: Pharmacotherapeutic: ZINC-BASED DRUGS, ATC code D02AB

(D: Dermatology).
Hypersensitivity to lanolin or to any of the other constituents mentioned in section Composition

ยท Infected lesions.

This medicinal product contains lanolin and may cause local skin reactions (eg eczema).

In the absence of data on transcutaneous resorption, the risk of systemic effects can not be ruled out, it is even more to be feared that the topical is used on a large surface under occlusive dressing on a (In particular burnt), mucous membrane, premature or infant skin (due to the surface / weight ratio and the occlusal effect of the layers at the level of the seat). >

The data available to date do not imply the existence of clinically significant interactions.

No cases of overdose have been reported.

Possible contact eczema caused by lanolin

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorization of the drug is important. It permits continuous monitoring of the benefit / risk ratio of the drug. Health professionals must report any adverse reactions suspected through the national reporting system: National Agency for the Safety of Medicines and Health Products (Ansm) and Network of Regional Centers for Pharmacovigilance. Ansm.sante.fr.

Local treatment to supplement skin ulcers.